| CXHL1401640 | 阿普斯特 | apremilast | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2015-01-19 | 广州艾格生物科技有限公司 | Guangzhou Aige Biotechnology Co Ltd | Accepted | 2014-10-29 | view |
| CXHL1401641 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-01-19 | 广州艾格生物科技有限公司 | Guangzhou Aige Biotechnology Co Ltd | Accepted | 2014-10-29 | view |
| CXHL1401642 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-01-19 | 广州艾格生物科技有限公司 | Guangzhou Aige Biotechnology Co Ltd | Accepted | 2014-10-29 | view |
| CXHL1401643 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-01-19 | 广州艾格生物科技有限公司 | Guangzhou Aige Biotechnology Co Ltd | Accepted | 2014-10-29 | view |
| CXHL1401943 | 阿普斯特 | apremilast | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2014-12-29 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-04-21 | view |
| CXHL1401944 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-12-29 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-04-21 | view |
| CXHL1401945 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-12-29 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-04-21 | view |
| CXHL1401946 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-12-29 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-04-21 | view |
| CXHL1500005 | 阿普司特 | apremilast | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 南京华威医药科技开发有限公司 | Nanjing Huawei Medicine Technology Development Co Ltd | Certificate Issued | 2016-05-12 | view |
| CXHL1500006 | 阿普司特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 南京华威医药科技开发有限公司 | Nanjing Huawei Medicine Technology Development Co Ltd | Certificate Issued | 2016-05-12 | view |
| CXHL1500007 | 阿普司特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 南京华威医药科技开发有限公司 | Nanjing Huawei Medicine Technology Development Co Ltd | Certificate Issued | 2016-05-12 | view |
| CXHL1500010 | 阿普斯特 | apremilast | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2015-01-27 | 南京海纳医药科技有限公司 | Nanjing Healthnice Pharmaceutical Technology Co Ltd | Certificate Issued | 2016-05-04 | view |
| CXHL1500011 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-01-27 | 南京海纳医药科技有限公司 | Nanjing Healthnice Pharmaceutical Technology Co Ltd | Certificate Issued | 2016-05-04 | view |
| CXHL1500012 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-01-27 | 南京海纳医药科技有限公司 | Nanjing Healthnice Pharmaceutical Technology Co Ltd | Certificate Issued | 2016-05-04 | view |
| CXHL1500013 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-01-27 | 南京海纳医药科技有限公司 | Nanjing Healthnice Pharmaceutical Technology Co Ltd | Certificate Issued | 2016-05-04 | view |
| CXHL1500026 | 阿普斯特 | apremilast | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 成都盛迪医药有限公司 | Chengdu Suncadia Medicine Co Ltd | Certificate Issued | 2016-05-04 | view |
| CXHL1500027 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 成都盛迪医药有限公司 | Chengdu Suncadia Medicine Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXHL1500028 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 成都盛迪医药有限公司 | Chengdu Suncadia Medicine Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXHL1500045 | 阿普斯特 | apremilast | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2015-02-05 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXHL1500046 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-05 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-05-11 | view |
